E-FORCSE Home Page
Important Legislative Update
On February 14, 2017, a designee of a prescriber or dispenser may have direct access to the controlled substance dispensing information in the E-FORCSE® database by registering on the E-FORCSE® secure web portal.How It Affects Me:
As a prescriber or dispenser, you may designate another individual to have direct access to controlled substance dispensing information in the E-FORCSE® database on your behalf. As the designating prescriber or dispenser, you must affirmatively accept responsibility for the designee’s actions within the database and ensure that the required training is completed.
The 2016 Florida Legislature passed Senate Bill 964 authorizing direct access to controlled substance dispensing information within the E-FORCSE® database to a designee of a prescriber or dispenser. Florida Administrative Code rule 64K-1.003(3) sets forth the requirements for access, and requires the prescriber or dispenser to certify that the designee has reviewed the “Training Guide for Florida Practitioners and Pharmacists” and the “Information Security and Privacy Course for Designees.”
Action Steps Needed:
- Review the Training Guide for Florida Practitioners and Pharmacists and the Information Security and Privacy Course for Designees and provide certification of completion to the designating prescriber or dispenser.
- Register for access on the E-FORCSE® secure web portal at using the temporary user name “newacct” and temporary password “welcome.” (NOTE: The designee will receive a user name and password, however the designee will NOT have direct access to information until the prescriber or dispenser has accepted responsibility for the designee and linked the account.)
- Inform the designating prescriber or dispenser that registration has been completed and that the designee is available for linking.
- Review the Training Guide for Practitioners and Pharmacists and Florida Administrative Code rule 64K-1.003, for updates regarding designee access to E-FORCSE® and the designating prescriber or dispensers’ responsibilities.
- Confirm that the designee has reviewed the Training Guide for Florida Practitioners and Pharmacists and the Information Security and Privacy Training Course for Designees and receive certifications of completion, to be stored on file.
- Follow the instructions in the Quick Reference Guide to Link a Designee to complete the designee linking process. NOTE: The designating prescriber or dispenser must accept responsibility for the designee’s activities in the E-FORCSE® database.
For technical assistance, contact the help desk at email@example.com.
Welcome to E-FORCSE®, Florida's Prescription Drug Monitoring Program
The Florida Prescription Drug Monitoring Program, known as E-FORCSE® (Electronic-Florida Online Reporting of Controlled Substance Evaluation Program), was created by the 2009 Florida Legislature in an initiative to encourage safer prescribing of controlled substances and to reduce drug abuse and diversion within the state of Florida.
E-FORCSE® has selected Health Information Designs, LLC, to develop a database that collects and stores prescribing and dispensing data for controlled substances in Schedules II, III, and IV. The purpose of the PDMP is to provide the information that is collected in the database to health care practitioners to guide their decisions in prescribing and dispensing these highly abused prescription drugs.
Section 893.055, Florida Statutes, requires health care practitioners to report to the PDMP each time a controlled substance is dispensed to an individual. The information is reported through the electronic system as soon as possible but not more than 7 days after dispensing. This reporting timeframe ensures that health care practitioners have the most up-to-date information available.
E-FORCSE® complies with the Health Insurance Portability and Accountability Act (HIPAA) as it pertains to protected health information (PHI), electronic protected health information (EPHI), and all other relevant state and federal privacy and security laws and regulations. The information collected in the system will be used by the PDMP to encourage safer prescribing of controlled substances and to reduce drug abuse and diversion within the state of Florida.
Pharmacy & Dispensing Practitioner Controlled Substance Reporting Requirements:The Department of Health’s Prescription Drug Monitoring Program called E-FORCSE collects, maintains, and stores controlled substance prescription dispensing information in its database and makes the information available to health care practitioners and law enforcement and regulatory agencies during active investigations. Section 893.055, F.S., requires all practitioners who dispense controlled substances listed in schedules II, III, or IV, as defined in section 893.03, F.S., to report to E-FORCSE within 7 days each time a controlled substance is dispensed to an individual, unless it is one of the acts of dispensing or administering which are exempt from reporting under subsection 893.055(5), F.S. For more information visit, http://www.floridahealth.gov/statistics-and-data/e-forcse/.
Wholesale Distributor, Manufacturer or Repackager Controlled Substance Reporting Requirements:The Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics Program, Controlled Substance Registry collects and stores controlled substance receipts and distributions in its registry. Section 499.0121(14), Florida Statutes (F.S.) requires each prescription drug wholesale distributor, whether in state or out-of-state, retail pharmacy drug wholesale distributor, manufacturer, or repackager that engages in the wholesale distribution of controlled substances to report receipts and distributions of controlled substances listed in Schedule II through V, as provided in s. 893.03, F.S., monthly by the 20th of the next month. For more information visit http://www.myfloridalicense.com/dbpr/ddc/CSR.html.
This project was supported by Grant No. 2009-PM-BX-4004 awarded by the Bureau of Justice Assistance, Office of Justice Program, U.S. Department of Justice.